Literature DB >> 31672020

Clinical Efficacy and Safety of Omalizumab in the Treatment of Allergic Rhinitis: A Systematic Review and Meta-analysis of Randomized Clinical Trials.

Chenjie Yu1,2,3, Kaijian Wang2, Xinyan Cui4, Ling Lu1,2,3, Jianfei Dong1,2,3, Maohua Wang5, Xia Gao1,2,3.   

Abstract

Entities:  

Keywords:  allergic rhinitis; anti-IgE; immunotherapy; meta-analysis; omalizumab

Mesh：

Substances：

Year:  2019        PMID： 31672020     DOI： 10.1177/1945892419884774

Source DB:  PubMed          Journal:  Am J Rhinol Allergy        ISSN： 1945-8932            Impact factor:   2.467


× No keyword cloud information.
  5 in total

Review 1.  Biologics for the Treatment of Allergic Rhinitis, Chronic Rhinosinusitis, and Nasal Polyposis.

Authors:  William Eschenbacher; Matthew Straesser; Alice Knoeddler; Rung-Chi Li; Larry Borish
Journal:  Immunol Allergy Clin North Am       Date:  2020-09-09       Impact factor: 3.479

Review 2.  Anti-IgE: A treatment option in allergic rhinitis?

Authors:  Oliver Pfaar; Francesca Gehrt; Hansen Li; Stefan A Rudhart; Alexander Nastev; Boris A Stuck; Stephan Hoch
Journal:  Allergol Select       Date:  2021-02-24

Review 3.  Pediatric usage of Omalizumab: A promising one.

Authors:  Lin Yu; Huishan Zhang; Jianwei Pan; Leping Ye
Journal:  World Allergy Organ J       Date:  2021-12-11       Impact factor: 4.084

Review 4.  Current and Future Approaches in Management of Chronic Spontaneous Urticaria Using Anti-IgE Antibodies.

Authors:  Olguța Anca Orzan; Liliana Gabriela Popa; Mara Mădălina Mihai; Anca Cojocaru; Călin Giurcăneanu; Alexandra Maria Dorobanțu
Journal:  Medicina (Kaunas)       Date:  2022-06-17       Impact factor: 2.948

Review 5.  Barrier Impairment and Type 2 Inflammation in Allergic Diseases: The Pediatric Perspective.

Authors:  Michele Ghezzi; Elena Pozzi; Luisa Abbattista; Luisa Lonoce; Gian Vincenzo Zuccotti; Enza D'Auria
Journal:  Children (Basel)       Date:  2021-12-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.